nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—breast cancer	0.171	0.546	CbGaD
Tolvaptan—ABCB1—breast cancer	0.142	0.454	CbGaD
Tolvaptan—ABCB1—Toremifene—breast cancer	0.0391	0.0909	CbGbCtD
Tolvaptan—CYP3A4—Exemestane—breast cancer	0.0338	0.0786	CbGbCtD
Tolvaptan—CYP3A4—Letrozole—breast cancer	0.0288	0.0668	CbGbCtD
Tolvaptan—ABCB1—Lapatinib—breast cancer	0.0285	0.0663	CbGbCtD
Tolvaptan—CYP3A4—Anastrozole—breast cancer	0.0256	0.0596	CbGbCtD
Tolvaptan—CYP3A4—Toremifene—breast cancer	0.0234	0.0545	CbGbCtD
Tolvaptan—CYP3A4—Fulvestrant—breast cancer	0.0218	0.0506	CbGbCtD
Tolvaptan—CYP3A4—Thiotepa—breast cancer	0.0194	0.0451	CbGbCtD
Tolvaptan—CYP3A4—Ixabepilone—breast cancer	0.0178	0.0413	CbGbCtD
Tolvaptan—CYP3A4—Lapatinib—breast cancer	0.0171	0.0397	CbGbCtD
Tolvaptan—ABCB1—Vinorelbine—breast cancer	0.0158	0.0368	CbGbCtD
Tolvaptan—ABCB1—Tamoxifen—breast cancer	0.0143	0.0332	CbGbCtD
Tolvaptan—ABCB1—Mitoxantrone—breast cancer	0.0139	0.0324	CbGbCtD
Tolvaptan—CYP3A4—Raloxifene—breast cancer	0.013	0.0301	CbGbCtD
Tolvaptan—ABCB1—Gemcitabine—breast cancer	0.0123	0.0286	CbGbCtD
Tolvaptan—ABCB1—Paclitaxel—breast cancer	0.0111	0.0258	CbGbCtD
Tolvaptan—ABCB1—Irinotecan—breast cancer	0.011	0.0255	CbGbCtD
Tolvaptan—ABCB1—Vinblastine—breast cancer	0.00976	0.0227	CbGbCtD
Tolvaptan—CYP3A4—Vinorelbine—breast cancer	0.00949	0.022	CbGbCtD
Tolvaptan—CYP3A4—Tamoxifen—breast cancer	0.00856	0.0199	CbGbCtD
Tolvaptan—CYP3A4—Mitoxantrone—breast cancer	0.00835	0.0194	CbGbCtD
Tolvaptan—ABCB1—Docetaxel—breast cancer	0.00804	0.0187	CbGbCtD
Tolvaptan—CYP3A4—Paclitaxel—breast cancer	0.00666	0.0155	CbGbCtD
Tolvaptan—CYP3A4—Irinotecan—breast cancer	0.00658	0.0153	CbGbCtD
Tolvaptan—ABCB1—Doxorubicin—breast cancer	0.006	0.0139	CbGbCtD
Tolvaptan—CYP3A4—Vinblastine—breast cancer	0.00585	0.0136	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—breast cancer	0.00581	0.0135	CbGbCtD
Tolvaptan—CYP3A4—Docetaxel—breast cancer	0.00482	0.0112	CbGbCtD
Tolvaptan—CYP3A4—Doxorubicin—breast cancer	0.00359	0.00835	CbGbCtD
Tolvaptan—Zafirlukast—ABCG2—breast cancer	0.000661	0.176	CrCbGaD
Tolvaptan—Zafirlukast—PTGS1—breast cancer	0.000566	0.151	CrCbGaD
Tolvaptan—Vismodegib—ABCG2—breast cancer	0.00056	0.149	CrCbGaD
Tolvaptan—Conivaptan—CYP3A4—breast cancer	0.000495	0.132	CrCbGaD
Tolvaptan—Zafirlukast—CYP2D6—breast cancer	0.000385	0.103	CrCbGaD
Tolvaptan—Zafirlukast—CYP3A4—breast cancer	0.000331	0.088	CrCbGaD
Tolvaptan—Vismodegib—CYP3A4—breast cancer	0.00028	0.0745	CrCbGaD
Tolvaptan—Vismodegib—ALB—breast cancer	0.000244	0.065	CrCbGaD
Tolvaptan—Vismodegib—ABCB1—breast cancer	0.000233	0.062	CrCbGaD
Tolvaptan—Hypersensitivity—Vinorelbine—breast cancer	0.000104	0.000612	CcSEcCtD
Tolvaptan—Blood creatinine increased—Epirubicin—breast cancer	0.000104	0.000608	CcSEcCtD
Tolvaptan—Headache—Tamoxifen—breast cancer	0.000104	0.000608	CcSEcCtD
Tolvaptan—Angiopathy—Docetaxel—breast cancer	0.000103	0.000604	CcSEcCtD
Tolvaptan—Dehydration—Epirubicin—breast cancer	0.000103	0.000604	CcSEcCtD
Tolvaptan—Hyponatraemia—Doxorubicin—breast cancer	0.000103	0.000603	CcSEcCtD
Tolvaptan—Immune system disorder—Docetaxel—breast cancer	0.000103	0.000602	CcSEcCtD
Tolvaptan—Loss of consciousness—Paclitaxel—breast cancer	0.000103	0.000601	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.000103	0.000601	CcSEcCtD
Tolvaptan—Mediastinal disorder—Docetaxel—breast cancer	0.000102	0.0006	CcSEcCtD
Tolvaptan—Cardiac disorder—Capecitabine—breast cancer	0.000102	0.000599	CcSEcCtD
Tolvaptan—Asthenia—Vinorelbine—breast cancer	0.000102	0.000596	CcSEcCtD
Tolvaptan—Decreased appetite—Irinotecan—breast cancer	0.000102	0.000595	CcSEcCtD
Tolvaptan—Decreased appetite—Mitoxantrone—breast cancer	0.000102	0.000595	CcSEcCtD
Tolvaptan—Nausea—Vinblastine—breast cancer	0.000101	0.000593	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Epirubicin—breast cancer	0.000101	0.000593	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Irinotecan—breast cancer	0.000101	0.000591	CcSEcCtD
Tolvaptan—Pruritus—Vinorelbine—breast cancer	0.0001	0.000587	CcSEcCtD
Tolvaptan—Breast disorder—Epirubicin—breast cancer	0.0001	0.000587	CcSEcCtD
Tolvaptan—Constipation—Mitoxantrone—breast cancer	9.99e-05	0.000585	CcSEcCtD
Tolvaptan—Constipation—Irinotecan—breast cancer	9.99e-05	0.000585	CcSEcCtD
Tolvaptan—Angiopathy—Capecitabine—breast cancer	9.99e-05	0.000585	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Epirubicin—breast cancer	9.98e-05	0.000585	CcSEcCtD
Tolvaptan—Hypersensitivity—Thiotepa—breast cancer	9.97e-05	0.000584	CcSEcCtD
Tolvaptan—Immune system disorder—Capecitabine—breast cancer	9.94e-05	0.000583	CcSEcCtD
Tolvaptan—Mediastinal disorder—Capecitabine—breast cancer	9.92e-05	0.000581	CcSEcCtD
Tolvaptan—Headache—Goserelin—breast cancer	9.91e-05	0.000581	CcSEcCtD
Tolvaptan—Malnutrition—Docetaxel—breast cancer	9.9e-05	0.00058	CcSEcCtD
Tolvaptan—Decreased appetite—Gemcitabine—breast cancer	9.89e-05	0.00058	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	9.87e-05	0.000578	CcSEcCtD
Tolvaptan—Nausea—Tamoxifen—breast cancer	9.84e-05	0.000576	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Gemcitabine—breast cancer	9.83e-05	0.000576	CcSEcCtD
Tolvaptan—Discomfort—Paclitaxel—breast cancer	9.82e-05	0.000575	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Epirubicin—breast cancer	9.78e-05	0.000573	CcSEcCtD
Tolvaptan—Constipation—Gemcitabine—breast cancer	9.73e-05	0.00057	CcSEcCtD
Tolvaptan—Decreased appetite—Fluorouracil—breast cancer	9.73e-05	0.00057	CcSEcCtD
Tolvaptan—Dry mouth—Paclitaxel—breast cancer	9.72e-05	0.00057	CcSEcCtD
Tolvaptan—Asthenia—Thiotepa—breast cancer	9.71e-05	0.000569	CcSEcCtD
Tolvaptan—Diarrhoea—Vinorelbine—breast cancer	9.69e-05	0.000568	CcSEcCtD
Tolvaptan—Dysgeusia—Docetaxel—breast cancer	9.69e-05	0.000568	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Fluorouracil—breast cancer	9.66e-05	0.000566	CcSEcCtD
Tolvaptan—Nausea—Melphalan—breast cancer	9.63e-05	0.000564	CcSEcCtD
Tolvaptan—Feeling abnormal—Mitoxantrone—breast cancer	9.63e-05	0.000564	CcSEcCtD
Tolvaptan—Feeling abnormal—Irinotecan—breast cancer	9.63e-05	0.000564	CcSEcCtD
Tolvaptan—Blood creatinine increased—Doxorubicin—breast cancer	9.61e-05	0.000563	CcSEcCtD
Tolvaptan—Malnutrition—Capecitabine—breast cancer	9.58e-05	0.000561	CcSEcCtD
Tolvaptan—Pruritus—Thiotepa—breast cancer	9.57e-05	0.000561	CcSEcCtD
Tolvaptan—Dehydration—Doxorubicin—breast cancer	9.54e-05	0.000559	CcSEcCtD
Tolvaptan—Anaphylactic shock—Paclitaxel—breast cancer	9.53e-05	0.000558	CcSEcCtD
Tolvaptan—Nausea—Goserelin—breast cancer	9.4e-05	0.000551	CcSEcCtD
Tolvaptan—Dysgeusia—Capecitabine—breast cancer	9.38e-05	0.00055	CcSEcCtD
Tolvaptan—Feeling abnormal—Gemcitabine—breast cancer	9.38e-05	0.00055	CcSEcCtD
Tolvaptan—Shock—Paclitaxel—breast cancer	9.37e-05	0.000549	CcSEcCtD
Tolvaptan—Dizziness—Vinorelbine—breast cancer	9.37e-05	0.000549	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Doxorubicin—breast cancer	9.37e-05	0.000549	CcSEcCtD
Tolvaptan—Nervous system disorder—Paclitaxel—breast cancer	9.34e-05	0.000548	CcSEcCtD
Tolvaptan—Breast disorder—Doxorubicin—breast cancer	9.27e-05	0.000543	CcSEcCtD
Tolvaptan—Diarrhoea—Thiotepa—breast cancer	9.26e-05	0.000542	CcSEcCtD
Tolvaptan—Skin disorder—Paclitaxel—breast cancer	9.26e-05	0.000542	CcSEcCtD
Tolvaptan—Body temperature increased—Mitoxantrone—breast cancer	9.24e-05	0.000541	CcSEcCtD
Tolvaptan—Body temperature increased—Irinotecan—breast cancer	9.24e-05	0.000541	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Doxorubicin—breast cancer	9.24e-05	0.000541	CcSEcCtD
Tolvaptan—Feeling abnormal—Fluorouracil—breast cancer	9.22e-05	0.00054	CcSEcCtD
Tolvaptan—Anorexia—Paclitaxel—breast cancer	9.08e-05	0.000532	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—breast cancer	9.05e-05	0.00053	CcSEcCtD
Tolvaptan—Body temperature increased—Gemcitabine—breast cancer	9e-05	0.000527	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—breast cancer	8.97e-05	0.000526	CcSEcCtD
Tolvaptan—Dizziness—Thiotepa—breast cancer	8.95e-05	0.000524	CcSEcCtD
Tolvaptan—Ill-defined disorder—Capecitabine—breast cancer	8.89e-05	0.000521	CcSEcCtD
Tolvaptan—Headache—Vinorelbine—breast cancer	8.88e-05	0.00052	CcSEcCtD
Tolvaptan—Syncope—Docetaxel—breast cancer	8.87e-05	0.00052	CcSEcCtD
Tolvaptan—Pollakiuria—Epirubicin—breast cancer	8.85e-05	0.000519	CcSEcCtD
Tolvaptan—Body temperature increased—Fluorouracil—breast cancer	8.85e-05	0.000518	CcSEcCtD
Tolvaptan—Loss of consciousness—Docetaxel—breast cancer	8.7e-05	0.00051	CcSEcCtD
Tolvaptan—Hyperglycaemia—Epirubicin—breast cancer	8.64e-05	0.000506	CcSEcCtD
Tolvaptan—Malaise—Capecitabine—breast cancer	8.64e-05	0.000506	CcSEcCtD
Tolvaptan—Hypersensitivity—Mitoxantrone—breast cancer	8.61e-05	0.000504	CcSEcCtD
Tolvaptan—Hypersensitivity—Irinotecan—breast cancer	8.61e-05	0.000504	CcSEcCtD
Tolvaptan—Syncope—Capecitabine—breast cancer	8.59e-05	0.000503	CcSEcCtD
Tolvaptan—Headache—Thiotepa—breast cancer	8.48e-05	0.000497	CcSEcCtD
Tolvaptan—Loss of consciousness—Capecitabine—breast cancer	8.42e-05	0.000493	CcSEcCtD
Tolvaptan—Nausea—Vinorelbine—breast cancer	8.42e-05	0.000493	CcSEcCtD
Tolvaptan—Renal failure—Epirubicin—breast cancer	8.4e-05	0.000492	CcSEcCtD
Tolvaptan—Asthenia—Irinotecan—breast cancer	8.38e-05	0.000491	CcSEcCtD
Tolvaptan—Asthenia—Mitoxantrone—breast cancer	8.38e-05	0.000491	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	8.37e-05	0.00049	CcSEcCtD
Tolvaptan—Decreased appetite—Paclitaxel—breast cancer	8.28e-05	0.000485	CcSEcCtD
Tolvaptan—Hypersensitivity—Fluorouracil—breast cancer	8.24e-05	0.000483	CcSEcCtD
Tolvaptan—Dry mouth—Docetaxel—breast cancer	8.24e-05	0.000483	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Paclitaxel—breast cancer	8.23e-05	0.000482	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—breast cancer	8.19e-05	0.00048	CcSEcCtD
Tolvaptan—Asthenia—Gemcitabine—breast cancer	8.17e-05	0.000478	CcSEcCtD
Tolvaptan—Constipation—Paclitaxel—breast cancer	8.15e-05	0.000477	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	8.1e-05	0.000475	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—breast cancer	8.09e-05	0.000474	CcSEcCtD
Tolvaptan—Anaphylactic shock—Docetaxel—breast cancer	8.08e-05	0.000473	CcSEcCtD
Tolvaptan—Discomfort—Capecitabine—breast cancer	8.06e-05	0.000472	CcSEcCtD
Tolvaptan—Pruritus—Gemcitabine—breast cancer	8.05e-05	0.000472	CcSEcCtD
Tolvaptan—Nausea—Thiotepa—breast cancer	8.04e-05	0.000471	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—breast cancer	8.03e-05	0.000471	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—breast cancer	8e-05	0.000469	CcSEcCtD
Tolvaptan—Diarrhoea—Mitoxantrone—breast cancer	7.99e-05	0.000468	CcSEcCtD
Tolvaptan—Diarrhoea—Irinotecan—breast cancer	7.99e-05	0.000468	CcSEcCtD
Tolvaptan—Dry mouth—Capecitabine—breast cancer	7.98e-05	0.000467	CcSEcCtD
Tolvaptan—Shock—Docetaxel—breast cancer	7.95e-05	0.000466	CcSEcCtD
Tolvaptan—Nervous system disorder—Docetaxel—breast cancer	7.92e-05	0.000464	CcSEcCtD
Tolvaptan—Pruritus—Fluorouracil—breast cancer	7.92e-05	0.000464	CcSEcCtD
Tolvaptan—Feeling abnormal—Paclitaxel—breast cancer	7.85e-05	0.00046	CcSEcCtD
Tolvaptan—Skin disorder—Docetaxel—breast cancer	7.85e-05	0.00046	CcSEcCtD
Tolvaptan—Diarrhoea—Gemcitabine—breast cancer	7.79e-05	0.000456	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—breast cancer	7.77e-05	0.000455	CcSEcCtD
Tolvaptan—Dizziness—Irinotecan—breast cancer	7.73e-05	0.000453	CcSEcCtD
Tolvaptan—Anorexia—Docetaxel—breast cancer	7.7e-05	0.000451	CcSEcCtD
Tolvaptan—Shock—Capecitabine—breast cancer	7.69e-05	0.000451	CcSEcCtD
Tolvaptan—Nervous system disorder—Capecitabine—breast cancer	7.67e-05	0.000449	CcSEcCtD
Tolvaptan—Diarrhoea—Fluorouracil—breast cancer	7.66e-05	0.000449	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—breast cancer	7.6e-05	0.000446	CcSEcCtD
Tolvaptan—Skin disorder—Capecitabine—breast cancer	7.6e-05	0.000445	CcSEcCtD
Tolvaptan—Urinary tract disorder—Epirubicin—breast cancer	7.57e-05	0.000444	CcSEcCtD
Tolvaptan—Connective tissue disorder—Epirubicin—breast cancer	7.54e-05	0.000442	CcSEcCtD
Tolvaptan—Body temperature increased—Paclitaxel—breast cancer	7.53e-05	0.000441	CcSEcCtD
Tolvaptan—Urethral disorder—Epirubicin—breast cancer	7.52e-05	0.00044	CcSEcCtD
Tolvaptan—Anorexia—Capecitabine—breast cancer	7.45e-05	0.000437	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—breast cancer	7.43e-05	0.000436	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—breast cancer	7.4e-05	0.000434	CcSEcCtD
Tolvaptan—Dizziness—Fluorouracil—breast cancer	7.4e-05	0.000434	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—breast cancer	7.38e-05	0.000433	CcSEcCtD
Tolvaptan—Headache—Irinotecan—breast cancer	7.32e-05	0.000429	CcSEcCtD
Tolvaptan—Headache—Mitoxantrone—breast cancer	7.32e-05	0.000429	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—breast cancer	7.13e-05	0.000418	CcSEcCtD
Tolvaptan—Headache—Gemcitabine—breast cancer	7.13e-05	0.000418	CcSEcCtD
Tolvaptan—Cardiac disorder—Epirubicin—breast cancer	7.12e-05	0.000417	CcSEcCtD
Tolvaptan—Decreased appetite—Docetaxel—breast cancer	7.02e-05	0.000411	CcSEcCtD
Tolvaptan—Hypersensitivity—Paclitaxel—breast cancer	7.02e-05	0.000411	CcSEcCtD
Tolvaptan—Headache—Fluorouracil—breast cancer	7.01e-05	0.000411	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—breast cancer	7.01e-05	0.000411	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—breast cancer	6.98e-05	0.000409	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Docetaxel—breast cancer	6.97e-05	0.000409	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—breast cancer	6.97e-05	0.000409	CcSEcCtD
Tolvaptan—Angiopathy—Epirubicin—breast cancer	6.96e-05	0.000408	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—breast cancer	6.95e-05	0.000408	CcSEcCtD
Tolvaptan—Nausea—Irinotecan—breast cancer	6.94e-05	0.000407	CcSEcCtD
Tolvaptan—Nausea—Mitoxantrone—breast cancer	6.94e-05	0.000407	CcSEcCtD
Tolvaptan—Immune system disorder—Epirubicin—breast cancer	6.93e-05	0.000406	CcSEcCtD
Tolvaptan—Mediastinal disorder—Epirubicin—breast cancer	6.91e-05	0.000405	CcSEcCtD
Tolvaptan—Constipation—Docetaxel—breast cancer	6.91e-05	0.000405	CcSEcCtD
Tolvaptan—Asthenia—Paclitaxel—breast cancer	6.84e-05	0.000401	CcSEcCtD
Tolvaptan—Decreased appetite—Capecitabine—breast cancer	6.8e-05	0.000398	CcSEcCtD
Tolvaptan—Nausea—Gemcitabine—breast cancer	6.76e-05	0.000396	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Capecitabine—breast cancer	6.75e-05	0.000396	CcSEcCtD
Tolvaptan—Pruritus—Paclitaxel—breast cancer	6.74e-05	0.000395	CcSEcCtD
Tolvaptan—Constipation—Capecitabine—breast cancer	6.69e-05	0.000392	CcSEcCtD
Tolvaptan—Malnutrition—Epirubicin—breast cancer	6.68e-05	0.000391	CcSEcCtD
Tolvaptan—Feeling abnormal—Docetaxel—breast cancer	6.66e-05	0.00039	CcSEcCtD
Tolvaptan—Nausea—Fluorouracil—breast cancer	6.65e-05	0.000389	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—breast cancer	6.62e-05	0.000388	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—breast cancer	6.58e-05	0.000386	CcSEcCtD
Tolvaptan—Dysgeusia—Epirubicin—breast cancer	6.54e-05	0.000383	CcSEcCtD
Tolvaptan—Diarrhoea—Paclitaxel—breast cancer	6.52e-05	0.000382	CcSEcCtD
Tolvaptan—Feeling abnormal—Capecitabine—breast cancer	6.44e-05	0.000378	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—breast cancer	6.44e-05	0.000377	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—breast cancer	6.43e-05	0.000377	CcSEcCtD
Tolvaptan—Immune system disorder—Doxorubicin—breast cancer	6.41e-05	0.000375	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—breast cancer	6.39e-05	0.000375	CcSEcCtD
Tolvaptan—Body temperature increased—Docetaxel—breast cancer	6.38e-05	0.000374	CcSEcCtD
Tolvaptan—Dizziness—Paclitaxel—breast cancer	6.3e-05	0.000369	CcSEcCtD
Tolvaptan—Ill-defined disorder—Epirubicin—breast cancer	6.19e-05	0.000363	CcSEcCtD
Tolvaptan—Body temperature increased—Capecitabine—breast cancer	6.18e-05	0.000362	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—breast cancer	6.18e-05	0.000362	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—breast cancer	6.05e-05	0.000354	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.03e-05	0.000353	CcSEcCtD
Tolvaptan—Malaise—Epirubicin—breast cancer	6.02e-05	0.000353	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—breast cancer	6e-05	0.000352	CcSEcCtD
Tolvaptan—Syncope—Epirubicin—breast cancer	5.99e-05	0.000351	CcSEcCtD
Tolvaptan—Headache—Paclitaxel—breast cancer	5.97e-05	0.00035	CcSEcCtD
Tolvaptan—Hypersensitivity—Docetaxel—breast cancer	5.95e-05	0.000349	CcSEcCtD
Tolvaptan—Loss of consciousness—Epirubicin—breast cancer	5.87e-05	0.000344	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—breast cancer	5.82e-05	0.000341	CcSEcCtD
Tolvaptan—Asthenia—Docetaxel—breast cancer	5.79e-05	0.00034	CcSEcCtD
Tolvaptan—Hypersensitivity—Capecitabine—breast cancer	5.76e-05	0.000338	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—breast cancer	5.73e-05	0.000336	CcSEcCtD
Tolvaptan—Pruritus—Docetaxel—breast cancer	5.71e-05	0.000335	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—breast cancer	5.71e-05	0.000334	CcSEcCtD
Tolvaptan—Nausea—Paclitaxel—breast cancer	5.66e-05	0.000332	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—breast cancer	5.65e-05	0.000331	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.64e-05	0.000331	CcSEcCtD
Tolvaptan—Discomfort—Epirubicin—breast cancer	5.61e-05	0.000329	CcSEcCtD
Tolvaptan—Asthenia—Capecitabine—breast cancer	5.61e-05	0.000329	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—breast cancer	5.57e-05	0.000326	CcSEcCtD
Tolvaptan—Dry mouth—Epirubicin—breast cancer	5.56e-05	0.000326	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—breast cancer	5.55e-05	0.000325	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—breast cancer	5.54e-05	0.000325	CcSEcCtD
Tolvaptan—Pruritus—Capecitabine—breast cancer	5.53e-05	0.000324	CcSEcCtD
Tolvaptan—Diarrhoea—Docetaxel—breast cancer	5.53e-05	0.000324	CcSEcCtD
Tolvaptan—Anaphylactic shock—Epirubicin—breast cancer	5.45e-05	0.000319	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—breast cancer	5.43e-05	0.000318	CcSEcCtD
Tolvaptan—Shock—Epirubicin—breast cancer	5.36e-05	0.000314	CcSEcCtD
Tolvaptan—Diarrhoea—Capecitabine—breast cancer	5.35e-05	0.000313	CcSEcCtD
Tolvaptan—Nervous system disorder—Epirubicin—breast cancer	5.34e-05	0.000313	CcSEcCtD
Tolvaptan—Dizziness—Docetaxel—breast cancer	5.34e-05	0.000313	CcSEcCtD
Tolvaptan—Skin disorder—Epirubicin—breast cancer	5.29e-05	0.00031	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.22e-05	0.000306	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—breast cancer	5.2e-05	0.000304	CcSEcCtD
Tolvaptan—Anorexia—Epirubicin—breast cancer	5.19e-05	0.000304	CcSEcCtD
Tolvaptan—Dizziness—Capecitabine—breast cancer	5.17e-05	0.000303	CcSEcCtD
Tolvaptan—Dry mouth—Doxorubicin—breast cancer	5.14e-05	0.000301	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—breast cancer	5.06e-05	0.000297	CcSEcCtD
Tolvaptan—Headache—Docetaxel—breast cancer	5.06e-05	0.000296	CcSEcCtD
Tolvaptan—Anaphylactic shock—Doxorubicin—breast cancer	5.04e-05	0.000295	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—breast cancer	5.03e-05	0.000294	CcSEcCtD
Tolvaptan—Shock—Doxorubicin—breast cancer	4.96e-05	0.000291	CcSEcCtD
Tolvaptan—Nervous system disorder—Doxorubicin—breast cancer	4.94e-05	0.00029	CcSEcCtD
Tolvaptan—Headache—Capecitabine—breast cancer	4.9e-05	0.000287	CcSEcCtD
Tolvaptan—Skin disorder—Doxorubicin—breast cancer	4.9e-05	0.000287	CcSEcCtD
Tolvaptan—Anorexia—Doxorubicin—breast cancer	4.8e-05	0.000282	CcSEcCtD
Tolvaptan—Nausea—Docetaxel—breast cancer	4.8e-05	0.000281	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—breast cancer	4.8e-05	0.000281	CcSEcCtD
Tolvaptan—Decreased appetite—Epirubicin—breast cancer	4.74e-05	0.000277	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Epirubicin—breast cancer	4.7e-05	0.000276	CcSEcCtD
Tolvaptan—Constipation—Epirubicin—breast cancer	4.66e-05	0.000273	CcSEcCtD
Tolvaptan—Nausea—Capecitabine—breast cancer	4.64e-05	0.000272	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—breast cancer	4.6e-05	0.00027	CcSEcCtD
Tolvaptan—Feeling abnormal—Epirubicin—breast cancer	4.49e-05	0.000263	CcSEcCtD
Tolvaptan—Decreased appetite—Doxorubicin—breast cancer	4.38e-05	0.000257	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—breast cancer	4.35e-05	0.000255	CcSEcCtD
Tolvaptan—Constipation—Doxorubicin—breast cancer	4.31e-05	0.000253	CcSEcCtD
Tolvaptan—Body temperature increased—Epirubicin—breast cancer	4.31e-05	0.000252	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—breast cancer	4.29e-05	0.000251	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—breast cancer	4.18e-05	0.000245	CcSEcCtD
Tolvaptan—Feeling abnormal—Doxorubicin—breast cancer	4.15e-05	0.000243	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—breast cancer	4.12e-05	0.000241	CcSEcCtD
Tolvaptan—Hypersensitivity—Epirubicin—breast cancer	4.01e-05	0.000235	CcSEcCtD
Tolvaptan—Body temperature increased—Doxorubicin—breast cancer	3.98e-05	0.000233	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—breast cancer	3.98e-05	0.000233	CcSEcCtD
Tolvaptan—Asthenia—Epirubicin—breast cancer	3.91e-05	0.000229	CcSEcCtD
Tolvaptan—Pruritus—Epirubicin—breast cancer	3.85e-05	0.000226	CcSEcCtD
Tolvaptan—Dizziness—Methotrexate—breast cancer	3.85e-05	0.000226	CcSEcCtD
Tolvaptan—Diarrhoea—Epirubicin—breast cancer	3.73e-05	0.000218	CcSEcCtD
Tolvaptan—Hypersensitivity—Doxorubicin—breast cancer	3.71e-05	0.000218	CcSEcCtD
Tolvaptan—Headache—Methotrexate—breast cancer	3.65e-05	0.000214	CcSEcCtD
Tolvaptan—Asthenia—Doxorubicin—breast cancer	3.62e-05	0.000212	CcSEcCtD
Tolvaptan—Dizziness—Epirubicin—breast cancer	3.6e-05	0.000211	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—breast cancer	3.57e-05	0.000209	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—breast cancer	3.46e-05	0.000203	CcSEcCtD
Tolvaptan—Diarrhoea—Doxorubicin—breast cancer	3.45e-05	0.000202	CcSEcCtD
Tolvaptan—Headache—Epirubicin—breast cancer	3.41e-05	0.0002	CcSEcCtD
Tolvaptan—Dizziness—Doxorubicin—breast cancer	3.33e-05	0.000195	CcSEcCtD
Tolvaptan—Nausea—Epirubicin—breast cancer	3.24e-05	0.00019	CcSEcCtD
Tolvaptan—Headache—Doxorubicin—breast cancer	3.16e-05	0.000185	CcSEcCtD
Tolvaptan—Nausea—Doxorubicin—breast cancer	2.99e-05	0.000175	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—breast cancer	1.4e-05	0.000171	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.39e-05	0.000171	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—breast cancer	1.39e-05	0.00017	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDH1A1—breast cancer	1.37e-05	0.000168	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDH7A1—breast cancer	1.37e-05	0.000168	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.36e-05	0.000167	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.36e-05	0.000166	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—breast cancer	1.33e-05	0.000163	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.33e-05	0.000163	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MDM2—breast cancer	1.33e-05	0.000163	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—breast cancer	1.33e-05	0.000162	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RAF1—breast cancer	1.32e-05	0.000162	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MDM2—breast cancer	1.32e-05	0.000161	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RELA—breast cancer	1.32e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FHL2—breast cancer	1.32e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NME1—breast cancer	1.32e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADSL—breast cancer	1.32e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UMPS—breast cancer	1.32e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PHGDH—breast cancer	1.32e-05	0.000161	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RAF1—breast cancer	1.32e-05	0.000161	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NDUFS3—breast cancer	1.31e-05	0.000161	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ERBB2—breast cancer	1.31e-05	0.00016	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.31e-05	0.00016	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RELA—breast cancer	1.31e-05	0.00016	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ERBB2—breast cancer	1.3e-05	0.000159	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CB—breast cancer	1.29e-05	0.000158	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MTOR—breast cancer	1.29e-05	0.000158	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LDHB—breast cancer	1.29e-05	0.000158	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HPSE—breast cancer	1.29e-05	0.000158	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BRIP1—breast cancer	1.29e-05	0.000158	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CB—breast cancer	1.28e-05	0.000157	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MTOR—breast cancer	1.28e-05	0.000157	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.28e-05	0.000156	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.26e-05	0.000154	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—breast cancer	1.24e-05	0.000152	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—breast cancer	1.24e-05	0.000151	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CHST9—breast cancer	1.24e-05	0.000151	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—breast cancer	1.23e-05	0.000151	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.23e-05	0.00015	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—breast cancer	1.23e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCC1—breast cancer	1.22e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMMR—breast cancer	1.22e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA3—breast cancer	1.22e-05	0.00015	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1B—breast cancer	1.21e-05	0.000148	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1B—breast cancer	1.21e-05	0.000147	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—breast cancer	1.2e-05	0.000147	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—breast cancer	1.19e-05	0.000146	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—breast cancer	1.19e-05	0.000145	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—breast cancer	1.19e-05	0.000145	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARGC1B—breast cancer	1.19e-05	0.000145	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—breast cancer	1.18e-05	0.000145	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—breast cancer	1.18e-05	0.000144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—breast cancer	1.18e-05	0.000144	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.18e-05	0.000144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—breast cancer	1.17e-05	0.000143	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COX11—breast cancer	1.17e-05	0.000143	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.16e-05	0.000142	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—breast cancer	1.16e-05	0.000142	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JUN—breast cancer	1.16e-05	0.000141	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—breast cancer	1.15e-05	0.000141	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JUN—breast cancer	1.15e-05	0.00014	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CTNNB1—breast cancer	1.15e-05	0.00014	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CTNNB1—breast cancer	1.14e-05	0.000139	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.13e-05	0.000138	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.13e-05	0.000138	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—breast cancer	1.12e-05	0.000137	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1A—breast cancer	1.12e-05	0.000137	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA9—breast cancer	1.12e-05	0.000137	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA4—breast cancer	1.12e-05	0.000137	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTEN—breast cancer	1.12e-05	0.000137	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—breast cancer	1.12e-05	0.000136	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1A—breast cancer	1.11e-05	0.000136	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTEN—breast cancer	1.11e-05	0.000136	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.11e-05	0.000135	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—breast cancer	1.09e-05	0.000134	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA2—breast cancer	1.09e-05	0.000133	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX2—breast cancer	1.09e-05	0.000133	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—breast cancer	1.09e-05	0.000133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—breast cancer	1.09e-05	0.000133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—breast cancer	1.08e-05	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX4—breast cancer	1.08e-05	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SULT1A1—breast cancer	1.08e-05	0.000132	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SHMT1—breast cancer	1.07e-05	0.000131	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CDA—breast cancer	1.07e-05	0.000131	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTA1—breast cancer	1.05e-05	0.000129	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—IDH1—breast cancer	1.05e-05	0.000129	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.05e-05	0.000129	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.04e-05	0.000128	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NAT2—breast cancer	1.04e-05	0.000127	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SRC—breast cancer	1.04e-05	0.000127	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A5—breast cancer	1.03e-05	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.03e-05	0.000126	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SRC—breast cancer	1.03e-05	0.000126	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—breast cancer	1.01e-05	0.000123	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—breast cancer	1e-05	0.000123	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—breast cancer	1e-05	0.000122	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APRT—breast cancer	9.95e-06	0.000122	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—breast cancer	9.93e-06	0.000121	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	9.59e-06	0.000117	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK3—breast cancer	9.55e-06	0.000117	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK3—breast cancer	9.48e-06	0.000116	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ESRRA—breast cancer	9.36e-06	0.000114	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.36e-06	0.000114	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MYC—breast cancer	9.29e-06	0.000114	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	9.28e-06	0.000113	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—breast cancer	9.27e-06	0.000113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MYC—breast cancer	9.22e-06	0.000113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—breast cancer	9.2e-06	0.000112	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MED12—breast cancer	9.13e-06	0.000112	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DPYD—breast cancer	9.13e-06	0.000112	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—breast cancer	9.09e-06	0.000111	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—breast cancer	9.02e-06	0.00011	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDOA—breast cancer	8.99e-06	0.00011	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPI—breast cancer	8.87e-06	0.000108	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HADHB—breast cancer	8.87e-06	0.000108	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOA3—breast cancer	8.73e-06	0.000107	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A2—breast cancer	8.66e-06	0.000106	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—breast cancer	8.58e-06	0.000105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—breast cancer	8.52e-06	0.000104	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG2—breast cancer	8.49e-06	0.000104	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CPT1A—breast cancer	8.49e-06	0.000104	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTR—breast cancer	8.49e-06	0.000104	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.46e-06	0.000103	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.46e-06	0.000103	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HPGDS—breast cancer	8.32e-06	0.000102	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HBA1—breast cancer	8.27e-06	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NME1—breast cancer	8.12e-06	9.92e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FHL2—breast cancer	8.12e-06	9.92e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADSL—breast cancer	8.12e-06	9.92e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PHGDH—breast cancer	8.12e-06	9.92e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UMPS—breast cancer	8.12e-06	9.92e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTT1—breast cancer	8.07e-06	9.87e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ACHE—breast cancer	8.07e-06	9.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LDHB—breast cancer	7.96e-06	9.73e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BRIP1—breast cancer	7.96e-06	9.73e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HPSE—breast cancer	7.96e-06	9.73e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—breast cancer	7.89e-06	9.64e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.84e-06	9.58e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—breast cancer	7.83e-06	9.57e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP17A1—breast cancer	7.64e-06	9.34e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—breast cancer	7.63e-06	9.33e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—breast cancer	7.57e-06	9.26e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ENO1—breast cancer	7.57e-06	9.25e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS1—breast cancer	7.57e-06	9.25e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMMR—breast cancer	7.54e-06	9.22e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA3—breast cancer	7.54e-06	9.22e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCC1—breast cancer	7.54e-06	9.22e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2D6—breast cancer	7.42e-06	9.07e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.31e-06	8.93e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—breast cancer	7.3e-06	8.92e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOA2—breast cancer	7.28e-06	8.9e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—breast cancer	7.24e-06	8.86e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	7.08e-06	8.65e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FASN—breast cancer	7.06e-06	8.64e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BCHE—breast cancer	7.03e-06	8.6e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—breast cancer	6.98e-06	8.54e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC5A5—breast cancer	6.95e-06	8.49e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—breast cancer	6.93e-06	8.48e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA9—breast cancer	6.9e-06	8.44e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA4—breast cancer	6.9e-06	8.44e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX2—breast cancer	6.72e-06	8.22e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA2—breast cancer	6.72e-06	8.22e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A1—breast cancer	6.71e-06	8.2e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NQO1—breast cancer	6.71e-06	8.2e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX4—breast cancer	6.64e-06	8.12e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SULT1A1—breast cancer	6.64e-06	8.12e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP3A4—breast cancer	6.54e-06	8e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—IDH1—breast cancer	6.49e-06	7.93e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTA1—breast cancer	6.49e-06	7.93e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—breast cancer	6.44e-06	7.88e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1B1—breast cancer	6.43e-06	7.86e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NAT2—breast cancer	6.41e-06	7.84e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	6.4e-06	7.82e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—breast cancer	6.4e-06	7.82e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSP90AA1—breast cancer	6.31e-06	7.71e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOA1—breast cancer	6.14e-06	7.5e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP19A1—breast cancer	6.05e-06	7.39e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—STK11—breast cancer	6.05e-06	7.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MED12—breast cancer	5.62e-06	6.88e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DPYD—breast cancer	5.62e-06	6.88e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—COMT—breast cancer	5.62e-06	6.87e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTP1—breast cancer	5.6e-06	6.84e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDOA—breast cancer	5.54e-06	6.77e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—breast cancer	5.52e-06	6.75e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ITPR1—breast cancer	5.51e-06	6.73e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOA3—breast cancer	5.38e-06	6.57e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A2—breast cancer	5.34e-06	6.53e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTR—breast cancer	5.23e-06	6.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG2—breast cancer	5.23e-06	6.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CPT1A—breast cancer	5.23e-06	6.39e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TYMS—breast cancer	5.2e-06	6.36e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G4A—breast cancer	5.14e-06	6.29e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—breast cancer	5.14e-06	6.29e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOR1—breast cancer	5.14e-06	6.29e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HPGDS—breast cancer	5.13e-06	6.27e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HBA1—breast cancer	5.1e-06	6.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACHE—breast cancer	4.97e-06	6.08e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTT1—breast cancer	4.97e-06	6.08e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX1—breast cancer	4.92e-06	6.02e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1A1—breast cancer	4.87e-06	5.96e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ERCC2—breast cancer	4.83e-06	5.91e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP17A1—breast cancer	4.71e-06	5.76e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS1—breast cancer	4.66e-06	5.7e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ENO1—breast cancer	4.66e-06	5.7e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2D6—breast cancer	4.57e-06	5.59e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—breast cancer	4.54e-06	5.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOA2—breast cancer	4.49e-06	5.49e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FASN—breast cancer	4.35e-06	5.32e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BCHE—breast cancer	4.33e-06	5.3e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC5A5—breast cancer	4.28e-06	5.23e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAV1—breast cancer	4.19e-06	5.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A1—breast cancer	4.13e-06	5.05e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NQO1—breast cancer	4.13e-06	5.05e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1B1—breast cancer	3.96e-06	4.85e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.89e-06	4.75e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CG—breast cancer	3.82e-06	4.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOA1—breast cancer	3.78e-06	4.62e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—STK11—breast cancer	3.73e-06	4.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP19A1—breast cancer	3.73e-06	4.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COMT—breast cancer	3.46e-06	4.24e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTP1—breast cancer	3.45e-06	4.22e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—breast cancer	3.4e-06	4.16e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ITPR1—breast cancer	3.39e-06	4.15e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CD—breast cancer	3.36e-06	4.1e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—breast cancer	3.31e-06	4.05e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—breast cancer	3.26e-06	3.99e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TYMS—breast cancer	3.21e-06	3.92e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—breast cancer	3.17e-06	3.88e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.17e-06	3.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOR1—breast cancer	3.17e-06	3.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—breast cancer	3.17e-06	3.87e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX1—breast cancer	3.03e-06	3.71e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1A1—breast cancer	3e-06	3.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ERCC2—breast cancer	2.98e-06	3.64e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CB—breast cancer	2.93e-06	3.58e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—breast cancer	2.9e-06	3.54e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—breast cancer	2.8e-06	3.42e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAV1—breast cancer	2.58e-06	3.16e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTEN—breast cancer	2.53e-06	3.09e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CG—breast cancer	2.35e-06	2.88e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CD—breast cancer	2.07e-06	2.53e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—breast cancer	2.04e-06	2.5e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—breast cancer	1.95e-06	2.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CB—breast cancer	1.8e-06	2.2e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—breast cancer	1.79e-06	2.18e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—breast cancer	1.78e-06	2.18e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTEN—breast cancer	1.56e-06	1.9e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—breast cancer	1.46e-06	1.78e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—breast cancer	1.1e-06	1.34e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—breast cancer	8.98e-07	1.1e-05	CbGpPWpGaD
